These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17488408)

  • 1. Does progression from actinic keratosis and Bowen's disease end with treatment: diclofenac 3% gel, an old drug in a new environment?
    Patel MJ; Stockfleth E
    Br J Dermatol; 2007 May; 156 Suppl 3():53-6. PubMed ID: 17488408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two cases of Bowen's disease successfully treated topically with 3% diclofenac in 2.5% hyaluronan gel.
    Dawe SA; Salisbury JR; Higgins E
    Clin Exp Dermatol; 2005 Nov; 30(6):712-3. PubMed ID: 16197397
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).
    Nelson C; Rigel D; Smith S; Swanson N; Wolf J
    J Drugs Dermatol; 2004; 3(4):401-7. PubMed ID: 15303784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical 3% diclofenac in 2.5% hyaluronan gel for the treatment of actinic keratoses.
    Rivers JK
    Skin Therapy Lett; 2004 Jan; 9(1):1-3. PubMed ID: 14716439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases.
    Ulrich C; Hackethal M; Ulrich M; Howorka A; Forschner T; Sterry W; Stockfleth E
    Br J Dermatol; 2007 May; 156 Suppl 3():40-2. PubMed ID: 17488405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of actinic cheilitis using diclofenac 3% gel: a report of six cases.
    Ulrich C; Forschner T; Ulrich M; Stockfleth E; Sterry W; Termeer C
    Br J Dermatol; 2007 May; 156 Suppl 3():43-6. PubMed ID: 17488406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
    Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
    Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients.
    Dragieva G; Hafner J; Dummer R; Schmid-Grendelmeier P; Roos M; Prinz BM; Burg G; Binswanger U; Kempf W
    Transplantation; 2004 Jan; 77(1):115-21. PubMed ID: 14724445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses.
    Dirschka T; Bierhoff E; Pflugfelder A; Garbe C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):258-63. PubMed ID: 19709346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses.
    Rivers JK; McLean DI
    Arch Dermatol; 1997 Oct; 133(10):1239-42. PubMed ID: 9382562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically determined susceptibility to COX-2 inhibitors: a report of exaggerated responders to diclofenac 3% gel in the treatment of actinic keratoses.
    Patel MJ; Ulrich C; Forschner T
    Br J Dermatol; 2007 May; 156 Suppl 3():57-61. PubMed ID: 17488409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.
    Berlin JM; Rigel DS
    J Drugs Dermatol; 2008 Jul; 7(7):669-73. PubMed ID: 18664159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoallergic contact dermatitis from topical diclofenac in Solaraze gel.
    Kowalzick L; Ziegler H
    Contact Dermatitis; 2006 Jun; 54(6):348-9. PubMed ID: 16787462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety.
    Martin GM; Stockfleth E
    J Drugs Dermatol; 2012 May; 11(5):600-8. PubMed ID: 22527428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses.
    Mastrolonardo M
    Clin Exp Dermatol; 2009 Jan; 34(1):33-5. PubMed ID: 18616726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of disseminated superficial actinic porokeratosis with topical diclofenac gel: a case series.
    Vlachou C; Kanelleas AI; Martin-Clavijo A; Berth-Jones J
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1343-5. PubMed ID: 18554227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies.
    Pirard D; Vereecken P; Mélot C; Heenen M
    Arch Dermatol Res; 2005 Nov; 297(5):185-9. PubMed ID: 16235081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-arm, open-label efficacy and tolerability study of diclofenac sodium 3% gel for the treatment of actinic keratosis of the upper and lower lip.
    Nelson CG; Spencer J; Nelson CG
    J Drugs Dermatol; 2007 Jul; 6(7):712-7. PubMed ID: 17763595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy of nonmelanoma skin cancer with topical hypericum perforatum extract--a pilot study.
    Kacerovská D; Pizinger K; Majer F; Smíd F
    Photochem Photobiol; 2008; 84(3):779-85. PubMed ID: 18179625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical 3% diclofenac in 2.5% hyaluronic acid gel: a review of its use in patients with actinic keratoses.
    Jarvis B; Figgitt DP
    Am J Clin Dermatol; 2003; 4(3):203-13. PubMed ID: 12627996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.